Shanghai Pharmaceuticals Holding Co.Ltd(601607) : Shanghai Pharmaceuticals Holding Co.Ltd(601607) (Group) Co., Ltd.’s reply on abnormal fluctuation of Shanghai Pharmaceuticals Holding Co.Ltd(601607) stock trading Shanghai Pharmaceuticals Holding Co.Ltd(601607) : your inquiry email on abnormal fluctuation of Shanghai Pharmaceuticals Holding Co.Ltd(601607) stock trading sent on March 21 has been received. After verification by the company, the reply is as follows: as of the date of reply, the company has no major asset restructuring, share issuance, acquisition, debt restructuring, business restructuring, asset divestiture, asset injection, share repurchase, bankruptcy reorganization, major business cooperation, introduction of strategic investors and other major matters related to Shanghai Pharmaceuticals Holding Co.Ltd(601607) of the company. With this letter, please fulfill the obligation of information disclosure in time in accordance with the requirements of the regulatory authorities
© China Stock Market News